CIP2A and breast carcinoma: In breast cancer, the lncRNA-encoded micropeptide CIP2A-BP exhibited a direct binding affinity towards CIP2A, thereby the inhibition of PI3K-AKT-NFκB pathway led to a decrease in MMP2, MMP9, and Snail expression [77].